Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hamburg's FDA Reorganization Merges Budget And Policy Functions

This article was originally published in The Pink Sheet Daily

Executive Summary

Commissioner Hamburg says "we must be more successful in aligning our budget commitments with measurable outcomes."

FDA Commissioner Margaret Hamburg is reorganizing her direct staff reports to streamline the development and tracking of the agency's budget.

As part of the proposed reorganization, the Office of Policy, Planning and Preparedness is being dissolved and a new Office of Policy, Planning and Budget will be created, housing the Office of Policy, the Office of Planning and a newly created office, the Office of Budget. It will be headed by an associate commissioner for budget. Currently, the budget functions are handled in the Office of Operations, which is being trimmed down and re-launched the Office of Administration.

The new structure will be accompanied by new faces at FDA. It may also involve some departures: Randall Lutter, the current deputy commissioner for policy, planning and preparedness, and John Dyer, the chief operations officer, are absent from the proposed organizational chart included in a memo outlining the proposed changes.

The departure of Lutter and Dyer would be noteworthy because they are the last members of senior leadership team tapped by the Bush administration. Former Chief of Staff Susan Winckler departed June 19 (Also see "FDA Chief of Staff Vacancy Lets Hamburg Shape Leadership Team" - Pink Sheet, 19 Jun, 2009.).

Making the case for better funding

In the memo making the case for the new organization, Hamburg states, "Our program directors have been concerned for some time that we must be more successful in aligning our budget commitments with measurable outcomes."

"I intend to make the development and presentation of the agency's funding needs and performance goals among my highest personal priorities," Hamburg notes.

A focus on planning and budgeting has been one of the requests of congressional appropriators, and FDA's reorganization may help address the concerns of the purse string-holders on Capitol Hill.

Appropriations and authorizing committees have expressed willingness to provide FDA with more resources, and even as the agency's budget has gone up in recent years the increases have bee accompanied by comments that FDA needs a better plan for spending the funds (Also see "Congress Spars With FDA On Budget Figures And Scientific Readiness" - Pink Sheet, 4 Feb, 2008.).

Deputy commissioner for foods is new position

Among the other features of the reorganization is a new deputy commissioner for foods, who will oversee the Center for Food Safety and Applied Nutrition and the Center for Veterinary Medicine (see (Also see "FDA Reorganization Creates Deputy Commissioner Of Food" - Pink Sheet, 7 Jul, 2009.) ). "There is no higher priority than assuring the public that we intend to make the food safety program at FDA successful," Hamburg said.

Also as part of the reorganization, the Office of Chief Scientist will be streamlined to focus on innovation and integrity issues, and a new Office of Special Medical Programs will be created. The proposal also adds an Office of External Affairs and elevates the agency's crises management functions (see ).

-M. Nielsen Hobbs ([email protected])

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS069798

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel